Hodgkin Lymphoma News and Research

RSS
Researchers identify long-sought enzyme that prevents cancer

Researchers identify long-sought enzyme that prevents cancer

Targeted therapy achieves excellent outcomes, reduces side effects in high-risk Hodgkin lymphoma

Targeted therapy achieves excellent outcomes, reduces side effects in high-risk Hodgkin lymphoma

SwRI researchers part of two collaborative teams receive SAMF bioscience grants

SwRI researchers part of two collaborative teams receive SAMF bioscience grants

Underrepresentation in genomic databases may affect therapy selection for minority patients

Underrepresentation in genomic databases may affect therapy selection for minority patients

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

FISH technique can be used to probe sperm DNA for chromosomal defects

FISH technique can be used to probe sperm DNA for chromosomal defects

ADC histogram analysis can predict tumor proliferation, survival in immunocompetent patients with PCNSL

ADC histogram analysis can predict tumor proliferation, survival in immunocompetent patients with PCNSL

NCCN publishes new informational resources on health and wellness for cancer survivors

NCCN publishes new informational resources on health and wellness for cancer survivors

Cancer survivors have greater risk of developing and dying from subsequent primary cancers

Cancer survivors have greater risk of developing and dying from subsequent primary cancers

Researchers evaluate safety of novel therapy for patients with non-Hodgkin lymphoma

Researchers evaluate safety of novel therapy for patients with non-Hodgkin lymphoma

Testing for tumor DNA can help predict risk of relapse after transplant in DLBCL patients

Testing for tumor DNA can help predict risk of relapse after transplant in DLBCL patients

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Study: CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

Study: CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

More than 40 Dana-Farber studies to be presented at the virtual 62nd ASH Annual Meeting

More than 40 Dana-Farber studies to be presented at the virtual 62nd ASH Annual Meeting

Study finds increasing incidence of cancer among adolescents and young adults

Study finds increasing incidence of cancer among adolescents and young adults

Radiation therapy before CART-BCMA appears to be a safe option for multiple myeloma patients

Radiation therapy before CART-BCMA appears to be a safe option for multiple myeloma patients

A new therapeutic approach for Epstein-Barr virus-associated tumors

A new therapeutic approach for Epstein-Barr virus-associated tumors